Efthimios Skoulakis Research Group

USA (National and local grants for total of ~$ 500,000)

1990-1991. National Research Service Award Postdoctoral Fellow Reproductive Biology training grant. NSRA 5-T32-HD7165. Baylor College of Medicine. "Use of conditional courtship suppression to identify novel Drosophila learning mutants".

1992-1994. National Research Service Award Postdoctoral Fellow. Cold Spring Harbor Laboratory/Baylor College of Medicine, "Protein Kinase A mediated signaling in Drosophila melanogaster learning and memory.

1998-2000. Faculty Research Enhancement. Texas A&M University.

2000. TAMU–Interdisciplinary Grant Program. IRI 2000-50 "The role of microtubule binding protein in Drosophila learning and memory".

2000 -2003 NSF. Division of Integrative Biology and Neuroscience. Behavioral Neuroscience Program. IBN-0080687 "In vivo Functional Analysis of the role of 14-3-3 isoforms in Drosophila learning and memory'.

2001-2004. National Institute of Mental Health (Molecular and Cellular Neuroscience). R01MH59851. "Oncogenes in the Brain; DRK mediated signaling in Drosophila learning and memory."



GREECE (National and International grants for a total of > € 5.000.000)

2003-2006. PENED 2001. General Secretariat of Research and Technology Greece.
Title: Development of new diagnostic methods for nervous system diseases via functional analysis of the 14-3-3 and bHLH protein families in Drosophila.

2004-2006. EPAN 2002. General Secretariat of Research and Technology Greece
Title: Neural Stem cell therapies for Neurodegenerative diseases. Determination of a "molecular signature" for neuronal fate.

2004-2005. National Institutes of Health USA. Collaborative grant with T. Rouault NICHD
Title: Ferritin-dependent neurodegeneration in Drosophila.

2004-2006. Marie Curie International Return Grant.
Title: Functional analysis of signaling mechanisms in learning and memory.

2005-2008. Marie Curie Transfer of Knowledge Grant
Title: Genomic and Imaging approaches to intracellular signaling.

2005-2006. Industrial Contract: EnVivo Pharmaceuticals Boston Mass USA
Title: "Learning and memory assessment of AD Drosophila".

2006-2009 PENED 2004. General Secretariat of Research and Technology Greece.
Title: Mechanisms and pharmacological approach of synaptic function and plasticity in degenerating neurons.

2005-2008. AKMON 2004. General Secretariat of Research and Technology Greece.
Title: Development of transgenic services in disease models and macromolecular analysis at BSRC "Alexander Fleming"

ENTER 2006-2009. General Secretariat of Research and Technology Greece.
Title: Proteomic identification of molecular mechanisms that differentiate early dementia from degeneration in tauopathies.

2008-2011. March of Dimes USA-
Title: "A neuronal circuit-based investigation of the learning deficits associated with FXS and their pharmaceutical amelioration."

2009-2012. Fragile X Association USA -
Title: Efficient screening for pharmaceutical amelioration of FXS behavioural symptoms in Drosophila.

2011-2014. DARPA-USA Title: Quantum Biological Effects (QUBE). The fly quantum sensor

2012-2015. Greek Secretariat of Research and Technology 2012-2015.
Title: Study mechanisms of neurodegeneration in Alzheimer's disease.

2012-2015. Greek Secretariat of Research and Technology 2012-2015.
Title: Development and employment of Minos-based genetic and functional genomic technologies in model organisms.

2012-2015. March of Dimes USA-
Title: "Receptor Tyrosine Kinase Alk and Nf1-mediated signaling in learning."

2012-2015. Greek Secretariat of Research and Technology 2012-2015 ARISTEIA
Title: QUANTOLF. A fly quantum olfactory sensor.

2013-2016. European Commission FP7-ICT-2013-C
Title: Phonon-Assisted Processes for Energy Transfer and Sensing.

2013-2015. Fondaciοn Santé
Title: Identification of novel genetic modifiers of Neurofibromatosis Type-1 (NF1) learning disabilities in the fruit fly Drosophila melanogaster.

2015-2016. Greek Secretariat of Research and Technology KRIPIS
Strategic Development of the Alexander Fleming Institute for Biomedical Research. Drosophila models of human diseases

2015-2017. Greek Secretariat of Research and Technology/SIEMENS AWARD.
Title: Development of Novel Biomarkers and diagnostics for Tauopathies.

2017-2019. Fondaciοn Santé
Title: Elucidation of Habituation mechanisms through pharmacogenetics in Drosophila melanogaster.

2017-2019. Greek Secretariat of Research and Technology KRIPIS II
Title: Strategic Development of the Alexander Fleming Institute for Biomedical Research. Drosophila models of human diseases

2018-2021 Infrafrontier GR. Phenotypos
Title: Establishment of mouse Behavioral evaluation unit at the Alexander Fleming Institute for Biomedical Researc

2019-2020. Fondaciοn Santé
Title: Functional Tests of Psychiatric Disease comorbidity in Drosophila melanogaster.

2018-2020. Flagship Program: Greek Secretariat of Research and Technology
Title: The Olive Road, Electrophysiological evaluation of pheromonal detection of the olive fly Bactrocera oleae.

2020-2021. Flagship Program. Greek Secretariat of Research and Technology
Title: Cognitive pharmacology of bees in the field

2020-2021. Hellenic Ministry of Education and Religious affairs.
Title: Study of the differential effects of neuronal Tau isoforms on mobility and cognition in vivo

2021-2022. IONIS Pharmaceuticals CA-USA: Spintronic Radiofrequency Emission from Drosophila brains (collaborative with Dr. Luca Turin University of Buckingham UK)

2020-2023. Hellenic Foundation for Research and Innovation.
Title: Pharmacogenetics of habituation. An invertebrate model to validate schizophrenia-linked GWAS human loci.

2020-2024. Department of Defense USA
Title: An Interspecies Approach to Model Differential Cognitive Effects of Specific Neurofibromin I Mutations

2021-2023. Flagship Program: Experimental models of neurodenerative disease progression on the basis of precision medicine. Greek Secretariat of Research and Technology.

2022-2023. Children Tumour Foundation (USA)
Allele-specific behavioural pharmacogenetics of novel Nf1 mutations.